Increase Access

facebook twitter google print email
Media Contact:Holly Auer | holly.auer@uphs.upenn.edu | 215-349-5659August 11, 2011

Modified "Serial Killer" T Cells Obliterate Lymphocytic Leukemia Tumors, Penn Researchers Report

(PHILADELPHIA) -- In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells.

Stalled on the Job Front

August 6, 2011

Petra Todd of the School of Arts and Sciences answers questions about the job market.

Article Source: Philly.com

The Contributions of Mentees to Mentors

August 5, 2011

Marybeth Gasman of the Graduate School of Education discusses mentoring.

facebook twitter google print email

Combatting Flash Mobs and Youth Violence

 

Expert:

            Howard Stevenson
           Associate Professor, Graduate School of Education
            University of Pennsylvania

 

Credentials: